Pivotal bioVenture Partners Investment Advisor as of June 30, 2024
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 10 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 46.0 | $60M | 793k | 75.51 | |
| Inozyme Pharma (INZY) | 15.4 | $20M | 4.5M | 4.46 | |
| Oculis Holding Ordinary Shares (OCS) | 14.7 | $19M | 1.6M | 11.95 | |
| Arcutis Biotherapeutics (ARQT) | 14.6 | $19M | 2.0M | 9.30 | |
| Exscientia Ads (EXAI) | 3.0 | $3.9M | 771k | 5.10 | |
| Rallybio Corp (RLYB) | 2.5 | $3.2M | 2.4M | 1.34 | |
| Vigil Neuroscience (VIGL) | 1.7 | $2.2M | 561k | 4.00 | |
| Bolt Biotherapeutics | 1.1 | $1.4M | 1.9M | 0.75 | |
| Io Biotech (IOBT) | 0.8 | $1.0M | 864k | 1.17 | |
| Aligos Therapeutics | 0.2 | $260k | 743k | 0.35 |
